NEW YORK (GenomeWeb) – Molecular diagnostics firm Curetis has established a wholly owned subsidiary Ares Genetics that will focus on developing antibiotic resistance tests, the company said this week.

Ares Genetics, headquartered in Vienna, Austria, will harness the Genetic Antibiotic Resistance and Susceptibility Database (GEAR) that Curetis recently acquired from Siemens to understand the genetic basis for antibiotic resistance.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.